Temozolomide is a risk factor for invasive pulmonary aspergillosis: A case report and literature review-Reference-Cited by-同舟云学术

Temozolomide is a risk factor for invasive pulmonary aspergillosis: A case report and literature review

Published:2021-01 Issue: Volume: Page:
ISSN:2666-9919
Container-title:Infectious Diseases Now
language:en
Short-container-title:Infectious Diseases Now

Author:

Brault Clément,Zerbib Yoann,Chouaki Taieb,Maizel Julien,Nyga Rémy

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference10 articles.

1. Selective lymphopenia and opportunistic infections in neuroendocrine tumor patients receiving temozolomide;Schwarzberg;Cancer Invest,2007

2. Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and treatment of cancer and the mycoses Study Group Education and Research Consortium;Donnelly;Clin Infect Dis Off Publ Infect Dis Soc Am,2019

3. Invasive pulmonary aspergillosis: comparative analysis in cancer patients with underlying haematologic malignancies versus solid tumours;Dib;J Hosp Infect,2020

4. Aspergillus terreus brain abscess mimicking tumor progression in a patient with treated glioblastoma multiforme;Damek;Clin Neuropathol,2008

5. Cutaneous invasive aspergillosis in a patient with glioblastoma receiving long-term temozolomide and corticosteroid therapy;Ikeda;J Infect Chemother Off J Jpn Soc Chemother,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter;Neuro-Oncology;2022-05-02

2. Methylprednisolone/temozolomide;Reactions Weekly;2022-01